Hasil Pencarian - Chiara Crotti

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis

    Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis oleh Martina Biggioggero, Andrea Becciolini, Chiara Crotti, Elena Agape, Ennio Giulio Favalli

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Effectiveness and Tolerability of Repeated Courses of Viscosupplementation in Symptomatic Hip Osteoarthritis: A Retrospective Observational Cohort Study of High Molecular Weight vs. Medium Molecular Weight Hyaluronic Acid vs. No Viscosupplementation

    Effectiveness and Tolerability of Repeated Courses of Viscosupplementation in Symptomatic Hip Osteoarthritis: A Retrospective Observational Cohort Study of High Molecular Weight vs... oleh Orazio De Lucia, Luca Massimo Pierannunzii, Francesca Pregnolato, Elisa Verduci, Chiara Crotti, Chiara Crotti, Elisabetta Valcamonica, Elisabetta Valcamonica, Laura Pisoni, Laura Pisoni, Daniela Comi, Daniela Comi, Paola Adele Lonati, Pier Luigi Meroni, Antonella Murgo

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review

    Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review oleh Francesco Orsini, Chiara Crotti, Gilberto Cincinelli, Raffaele Di Taranto, Andrea Amati, Matteo Ferrito, Massimo Varenna, Roberto Caporali

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study

    Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study oleh Massimo Varenna, Davide Gatti, Francesca Zucchi, Chiara Crotti, Vania Braga, Giovanni Iolascon, Bruno Frediani, Fabrizio Nannipieri, Maurizio Rossini

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study

    Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study oleh Massimo Varenna, Vania Braga, Davide Gatti, Giovanni Iolascon, Bruno Frediani, Francesca Zucchi, Chiara Crotti, Fabrizio Nannipieri, Maurizio Rossini

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study

    Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study oleh Chiara Crotti, Raffaele Di Taranto, Raffaele Di Taranto, Francesco Orsini, Francesco Orsini, Matteo Ferrito, Matteo Ferrito, Massimo Varenna, Ennio Giulio Favalli, Ennio Giulio Favalli, Roberto Caporali, Roberto Caporali

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Osteoimmunology of Spondyloarthritis

    Osteoimmunology of Spondyloarthritis oleh Angelo Fassio, Fabiola Atzeni, Maurizio Rossini, Valeria D’Amico, Francesco Cantatore, Maria Sole Chimenti, Chiara Crotti, Bruno Frediani, Andrea Giusti, Giusy Peluso, Guido Rovera, Palma Scolieri, Vincenzo Raimondo, Davide Gatti, on behalf of the Study Group on Osteoporosis and Skeletal Metabolic Diseases of the Italian Society of Rheumatology

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: